WO2009008547A1 - Cell culture substrate - Google Patents
Cell culture substrate Download PDFInfo
- Publication number
- WO2009008547A1 WO2009008547A1 PCT/JP2008/062869 JP2008062869W WO2009008547A1 WO 2009008547 A1 WO2009008547 A1 WO 2009008547A1 JP 2008062869 W JP2008062869 W JP 2008062869W WO 2009008547 A1 WO2009008547 A1 WO 2009008547A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cell culture
- polymer chain
- culture substrate
- polystyrene
- skeleton
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0068—General culture methods using substrates
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/333—Polymers modified by chemical after-treatment with organic compounds containing nitrogen
- C08G65/33303—Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing amino group
- C08G65/33306—Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing amino group acyclic
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G81/00—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G81/00—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
- C08G81/02—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers at least one of the polymers being obtained by reactions involving only carbon-to-carbon unsaturated bonds
- C08G81/024—Block or graft polymers containing sequences of polymers of C08C or C08F and of polymers of C08G
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L25/00—Compositions of, homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an aromatic carbocyclic ring; Compositions of derivatives of such polymers
- C08L25/02—Homopolymers or copolymers of hydrocarbons
- C08L25/04—Homopolymers or copolymers of styrene
- C08L25/06—Polystyrene
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L51/00—Compositions of graft polymers in which the grafted component is obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers
- C08L51/08—Compositions of graft polymers in which the grafted component is obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers grafted on to macromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L67/00—Compositions of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Compositions of derivatives of such polymers
- C08L67/04—Polyesters derived from hydroxycarboxylic acids, e.g. lactones
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
- C08L71/02—Polyalkylene oxides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/20—Material Coatings
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G2650/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G2650/28—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule characterised by the polymer type
- C08G2650/50—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule characterised by the polymer type containing nitrogen, e.g. polyetheramines or Jeffamines(r)
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G2650/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G2650/28—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule characterised by the polymer type
- C08G2650/58—Ethylene oxide or propylene oxide copolymers, e.g. pluronics
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2205/00—Polymer mixtures characterised by other features
- C08L2205/05—Polymer mixtures characterised by other features containing polymer components which can react with one another
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L51/00—Compositions of graft polymers in which the grafted component is obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers
- C08L51/06—Compositions of graft polymers in which the grafted component is obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers grafted on to homopolymers or copolymers of aliphatic hydrocarbons containing only one carbon-to-carbon double bond
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L67/00—Compositions of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Compositions of derivatives of such polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
- C12N2533/40—Polyhydroxyacids, e.g. polymers of glycolic or lactic acid (PGA, PLA, PLGA); Bioresorbable polymers
Definitions
- the present invention relates to a cell culture substrate which is for use in culturing cells. More specifically, it relates to a cell culture substrate which can grow cells safely and efficiently without the need of immobilization and adsorption of a cell adhesion substance.
- regeneration medical treatment has attracted much interest as a new therapy.
- the basic concept of regeneration medical treatment is that functions of defective tissues and damaged organs are regeneratively repaired by promoting growth and differentiation of cells using cells or tissues artificially cultured to induce regeneration of self-tissues.
- cells are cultured in vitro, it is important that cells are cultured at high density upon maintaining the function of cells at the same level as in vivo.
- adhesion of the cells to the substrate surface is good and the adhered cells are in a state capable of extension, growth and migration.
- the cell culture has been so far performed using a glass, a culture dish made of polymer, a test tube, a culture bottle or the like.
- a high-molecular material, which has been hitherto used as a cell culture substrate, especially polystyrene is excellent in moldability, durability, transparency, nontoxicity and low cost.
- the surface of polystyrene is hydrophobic, it is not appropriate in view of cellular adhesiveness. Further, polystyrene has suffered from a problem that on the hydrophobic surface of polystyrene, uncontrollable interaction occurs between the cells and the adsorptive protein on the surface to cause adsorption and denaturation of the protein on the surface.
- a cell culture substrate in which the hydrophobic surface of polystyrene is subjected to corona discharge treatment to introduce an anion into the surface alone to impart hydrophilicity and improve the adhesiveness and growth of cells, has been developed and widely used.
- corona discharge treatment makes it hard to develop specific functions of cells and maintain the same for a long period of time.
- the extracellular matrix refers to a synthetic biopolymer which is synthesized in cells and excreted and accumulated extracellularly.
- the extracellular matrix is a structural support of a tissue precipitated around the cells, and it is a substance that controls cell adhesion, orientation of a cell skeleton, a cell form, cell migration, cell growth, intracellular metabolism and cell differentiation.
- Examples of the extracellular matrix include collagen as a main component, and fibronectin, laminin, vitronectin, proteoglycan and glycosaminoglycan as a second component.
- the cell adhesion factor refers to a factor which is present on a cell surface and is involved in adhesion of an intracellular or extracellular matrix.
- Examples of the factor which is involved in intracellular adhesion include cadherin family, Ig super family, selectin family and sialumtin family.
- Examples of the factor which is involved in adhesion of an extracellular matrix include integrin family.
- Examples of a culture substrate on which an extracellular matrix component for controlling adhesion and growth of cells is immobilized include a cell culture substrate coated with collagen (see, Non-patent Document 1), a cell culture substrate coated with fibronectin (see, Non-patent Document 2), and a cell culture substrate coated with a cell adhesion protein (see, Non-patent Document 3).
- Patent Document 1 JP-A-6-153905
- Patent Document 2 JP-T-2002-511496 (the term JP-T as used herein means a published Japanese translation of a PCT patent application)
- Patent Document 3 JP-A-2004-208692
- Non-patent Document 1 K. Yoshizato et al. Annals of Plastic Surgery. Vol. 13, No. 1 1984
- Non-patent Document 2 F. Grinnell. Expl. Cell Res., 102. 51. 1984
- Non-patent Document 3 P. T. Piccioano. et al., In Vitro Cellular and Developmental Biology 22(3). 24A. 1986
- the invention aims to provide, upon solving such ordinary problems, a cell culture substrate having excellent efficiency of cell culture without the need of immobilization and adsorption of a cell adhesion substance on a substrate surface.
- the present inventors have assiduously conducted investigations in consideration of the foregoing problems, and have consequently found that, according to a cell culture substrate in which a polymer chain having a hydrophilic skeleton is grafted onto a surface of polystyrene or poly( ⁇ -caprolactone) having a water contact angle of from 75° to 100°, efficiency of cell culture can be improved without the necessity of immobilization or adhesion of a cell adhesion substance.
- the invention has been completed based on this finding. That is, the invention relates to the following items 1 to 8.
- the cell culture substrate according to item 1 or 2 wherein the polymer chain having a hydrophilic skeleton is at least one member selected from the group consisting of polyethylene oxide, polypropylene oxide, and derivatives or copolymers thereof.
- a method for culturing cells which comprises using the cell culture substrate according to any one of items 1 to 4.
- a process for producing a cell culture substrate comprising steps of:
- the cell culture substrate of the invention makes it possible to improve efficiency of the cell culture without the necessity of immobilization or adsorption of the cell adhesion substance on the substrate surface.
- Fig. 1 shows results of evaluation of adsorption of a protein.
- Fig. 2 shows results of evaluation of efficiency of cell culture.
- the invention relates to a cell culture substrate in which a polymer chain having a hydrophilic skeleton is grafted to a hydrophobic polymer skeleton.
- the hydrophobic polymer used in the invention is a polymer having a water contact angle of from 75° to 100°.
- the water contact angle means a value which can be calculated by the following formula when a liquid droplet is put on a surface of a solid and equilibrium is reached in this atmosphere. The following formula is called "Young's formula", and an angle which is formed by a liquid surface and a solid surface is defined as a "contact angle”.
- ⁇ s represents a surface tension of a solid
- Y L represents a surface tension of a liquid
- ⁇ sL represents a solid/liquid surface tension
- ⁇ represents a contact angle
- the hydrophobic polymer may be either biodegradable or nonbiodegradable depending on a desired application. Further, it is preferable that the hydrophobic polymer is nontoxic, biocompatible and excellent in mechanical stability, transparency and moldability so as to be useful either in vivo or in vitro.
- hydrophobic polymer examples include engineering plastics such as polystyrene, polyethylene, polypropylene, polyester, polycarbonate, polyamide and polyacetal, and general-purpose polymers, and mixtures thereof.
- biodegradable polymers may be also used. Examples thereof include poly( ⁇ -caprolactone), polylactic acid, polyhydroxybutyric acid, polyethylene adipate and polybutylene carbonate. These biodegradable polymers are preferable in view of their in- vivo absorption when they are used in medical treatment.
- hydrophobic polymers polystyrene is preferable since the transparency, processability and strength thereof are excellent. Further, in view of easy procurement, cost and the like, poly( ⁇ -caprolactone) and polylactic acid are preferable. Moreover, in view of solubility in an organic solvent, polybutylene carbonate and polyethylene carbonate are preferable.
- polymers having a hydrophilic skeleton as used in the invention include polymers containing a hydroxyl group such as polyethylene glycol, polyethylene oxide, polypropylene glycol, polyvinyl alcohol, polyhydroxyethyl methacrylate and polypropylene oxide; polymers containing a vinyl group such as polyvinyl pyrrolidone; polymers containing an acid amide group such as polyacrylamide and polymethacrylamide; and copolymers with monomers constituting the same.
- polyethylene oxide, polypropylene oxide, and derivatives and copolymers thereof are preferable in view of the resistance properties to sterilization using radial ray. These may be used solely or two or more kinds thereof may be used in combination.
- the molecular weight of the polymer chain having a hydrophilic skeleton is from 500 to 2,000. This is because it is possible to maintain the orientation of the polymer chain well when the molecular weight of the polymer chain is within this range.
- the composition ratio thereof is not particularly limited, and the rate of the hydrophilic group contained in the molecule can be freely controlled by varying the ⁇ composition ratio.
- the polymer chain having a hydrophilic skeleton is grafted in an amount of 5 part by weight or more, more preferably 10 parts by weight or more, based on 100 parts by weight of the hydrophobic polymer skeleton. When the amount thereof is 5 parts by weight or more, it is possible to obtain sufficient hydrophilicity and it also becomes possible to graft the polymer chain having a hydrophilic skeleton uniformly.
- a method of grafting the polymer chain having a hydrophilic skeleton on the hydrophobic polymer skeleton is not particularly limited.
- the graft copolymerization include plasma graft copolymerization, photograft copolymerization and radiation graft copolymerization.
- plasma graft copolymerization is preferable, since introduction of a polar group such as an amino group, an amide group, a carboxyl group, a carbonyl group, an ester group or a hydroxyl group into the surface and formation of a chemical bond are enabled by selecting a type of a process gas used in a gas plasma treatment and wide-ranging usage is possible (see, for example, BJ.Jeong et al., J. Colloid Interf.Sci., 178, 757 (1996).).
- a polymer radical is previously formed on whole the molecular chain of a hydrophobic polymer by a high energy source to form a reactive functional group.
- Polymerization is then conducted in an aqueous solution of a polymer chain having a hydrophilic skeleton with a dehydrating agent or a reaction initiator (see, for example, Z.Cheng, S-H.Tech, Biomaterials 25 (2004) 1991-2001.).
- a dehydrating agent or a reaction initiator see, for example, Z.Cheng, S-H.Tech, Biomaterials 25 (2004) 1991-2001.
- the reactive functional group include a carboxyl group, a hydroxyl group, and an amino group.
- a polymer radical is previously formed on whole the molecular chain of a hydrophobic polymer by a high energy source, followed by being contacted with a reaction solution of a polymer chain having a hydrophilic skeleton which has a double bond to conduct a grafting (see, for example, Nakayama Y et. al., ASAIO, 39, M754- M757 (1993).).
- a reaction solution of a polymer chain having a hydrophilic skeleton which has a double bond to conduct a grafting see, for example, Nakayama Y et. al., ASAIO, 39, M754- M757 (1993).
- an end or one or more side chains of the polymer chain having the hydrophilic skeleton have a double bond.
- Examples of such a polymer chain having a hydrophilic skeleton include poly(N,N-dirnethylacryl amid) and polymethacryloyloxy alkylphosphoryl choline.
- a monomer forming a hydrophilic polymer skeleton is introduced into or contacted with a reaction system to conduct a radical polymerization via a radical reaction initiator (see, for example, Nakayama Y et.al., Macromolecules, 32, 5405-5410 (1999).).
- a radical reaction initiator see, for example, Nakayama Y et.al., Macromolecules, 32, 5405-5410 (1999).
- the radical reaction initiator include ⁇ , ⁇ '-azobisisobutyronitrile (AIBN) and benzoyl peroxide (BPO).
- the monomer or macromonomer having a polymerizable chain end include N-vinylacetamid, methyl acrylate, and methyl methacrylate.
- the surface of the hydrophobic polymer preferably has a water contact angle of from 25° to 60°.
- the cell culture substrate of the invention may have any form, and it may have a flat surface, a curved surface, a cylindrical surface or the like. Among these, it is preferably a flat surface in the step of grafting the polymer chain having a hydrophilic skeleton.
- the form of the substrate having a flat surface is provided by, for example, subjecting a base material to hot-melt pressing.
- a hydrophobic polymer is dissolved in an appropriate solvent, and the solution is subjected to a spin coating, dipping or casting on an inorganic material substrate such as a glass, a metal or a silicon wafer, or a substrate of polymer excellent in resistance to organic solvent, such as polypropylene, polyethylene or polyether ketone thereby forming the substrate having a flat surface.
- an inorganic material substrate such as a glass, a metal or a silicon wafer, or a substrate of polymer excellent in resistance to organic solvent, such as polypropylene, polyethylene or polyether ketone thereby forming the substrate having a flat surface.
- the inorganic material substrate is preferably used.
- the types of the cells which can be cultured on the cell culture substrate according to the invention are not particularly limited. Animal cells, especially adhesive cells may be mentioned.
- the cell culture substrate can widely be used in culturing, for example, fibroblasts, smooth muscle cells, vascular endothelial cells, corneal cells, cartilaginous cells, hepatic cells, small intestinal epithelial cells, epidermal keratinocytes, osteoblasts, bone marrow mesenchymal cells, germinal stem cells, adult stem cells, nerve stem cells and neurons, regardless of strain cells or primary cells. Further, it can be also used in culturing so-called floating cells such as blood cells.
- the cell culture substrate of the invention When the cell culture substrate of the invention is used, efficiency of the cell culture can be improved without the necessity of immobilization and adsorption of a cell adhesion substance such as an extracellular matrix or a cell adhesion factor.
- the cell culture substrate of the invention can be applied to substrates used so far in the cell culture, such as a petri dish, a plate, an incubator, a culture bag, a film, a fiber, a microcarrier and beads, or other substrates which can be used in the cell culture.
- a specific example of the process for producing the cell culture substrate according to the invention is a process comprising the following steps (1) to (2).
- Step (1) is a step of forming a surface of a hydrophobic polymer.
- the hydrophobic polymer is dissolved in a solvent such as chloroform or tetrahydrofuran in an amount of from 0.3 to 1.0% by mass to prepare a hydrophobic polymer aqueous solution.
- the hydrophobic polymer aqueous solution is spin-coated on a polymer substrate, and allowed to stand still and dried at room temperature to form a hydrophobic polymer-containing thin film having a film thickness of from 30 to 150 nm.
- the spin coating conditions satisfy a maximum rotational number of from 3,000 to 5,000 rpm and a period of from 30 to 60 seconds.
- Step (2) is a step of grafting a polymer chain having a hydrophilic skeleton onto the surface of the hydrophobic polymer skeleton formed in step (1).
- the grafting method is not particularly limited. However, grafting using the method (A) in accordance with plasma graft copolymerization is described herein.
- the hydrophobic polymer-containing thin film prepared in step (1) is allowed to stand still in a reactor of a low-pressure plasma generator (for example, Plasma Beam manufactured by Diner Electronic Corporation, or Micro Systems Apparatus manufactured by Roth & Rau AG), and an atmospheric pressure inside the reactor is adjusted to from 1 x 10 "3 to I x 10 "2 mbar using a vacuum pump.
- a low-pressure plasma generator for example, Plasma Beam manufactured by Diner Electronic Corporation, or Micro Systems Apparatus manufactured by Roth & Rau AG
- the hydrophobic polymer-containing thin film is treated with an output of 100 to 500 W for 10 to 600 seconds using a plasma generation source (for example, Electron Cyclotron Resonance manufactured by Roth & Rau AG, or radiofrequency wave generator manufactured by Roth & Rau AG) to generate plasma in the reactor.
- a plasma generation source for example, Electron Cyclotron Resonance manufactured by Roth & Rau AG, or radiofrequency wave generator manufactured by Roth & Rau AG
- a distance between the thin film and the plasma generation source is approximately 100 to 1,000 mm.
- the polymer chain having the hydrophilic skeleton is dissolved in a liquid compound such as water or phosphate buffer solution (PBS) in a proportion of from 5 to 20 raM to prepare a polymer chain aqueous solution having a hydrophilic skeleton, and pH is set at 7.0 to 7.5.
- a condensing agent such as diisopropylcarboziimide or 1 -ethyl-3 -(3 -dimetylaminopropyl)carboziimide hydrochloride may be dissolved, and a concentration of the condensing agent in the polymer aqueous solution may be set at 50 to 100 mM.
- the hydrophobic polymer-containing thin film treated with plasma in step (2) is dipped, and then allowed to stand still at room temperature for 12 to 24 hours. Thereafter, the thin film is rinsed with distilled water, and allowed to stand still and dried at room temperature.
- polystyrene represented by the following formula (1) was used as a hydrophobic polymer.
- Polystyrene manufactured by TOYO STYRENE: molecular weight approximately 4,300,000
- chloroform purchased from WAKO CHEMICAL
- the hydrophobic polymer solution was spin-coated on a silicon wafer (for measuring a contact angle) of 10 x 20 mm 2 or a cover glass (for cell culture) having a diameter of 15 mm to form a thin film having a film thickness of approximately 65 nm.
- the spin coating conditions were that a maximum rotational number was 3,000 rpm and a time was 30 seconds. After the spin coating, the product was allowed to stand still and dried at room temperature.
- an ultrathin film of less than 60 nm has to be formed on a metallic thin film sensor chip (measurable lower limit is 60 nm).
- polystyrene was dissolved in chloroform to adjust a concentration to 0.3% w/w, and the solution was spin-coated on the surface to form a thin film having a film thickness of approximately 30 nm.
- the spin coating conditions were that a maximum rotational number was 3,000 rpm and a time was 30 seconds. After the spin coating, the product was allowed to stand still and dried at room temperature.
- a polystyrene-containing thin film formed on a slide glass was allowed to stand still in a reactor of a low-pressure plasma generator, and an atmospheric pressure in the reactor was adjusted to 5 x 10 "3 mbar using a vacuum pump.
- An oxygen gas was used as a gas in the reactor, and a gas flow rate was 10 cm 3 /sec.
- Plasma was then generated in the reactor with an output of 250 W using a 2.46 GHz electron cyclotron resonance-type magnetic field microwave generation source. At this time, a distance between the sample and the plasma generation source was approximately 200 mm. The plasma treatment of the sample was conducted for 30 seconds.
- PO polypropylene oxide
- EO polyethylene oxide
- PO polypropylene oxide
- EO polyethylene oxide
- R is H in the case of EO, and R is CH 3 in the case ofPO.
- the polystyrene-containing thin film treated with oxygen plasma in the foregoing method was taken out of the reactor, immediately contacted with the polymer chain aqueous solution having a hydrophilic skeleton, and allowed to stand still at room temperature for 1 hour. Thereafter, the surface was rinsed with distilled water, and then allowed to stand still and dried at room temperature.
- Example 3 (Preparation of a surface of a poly- ⁇ -caprolactone)
- poly- ⁇ -caprolactone represented by the following formula 3 was used as a hydrophobic polymer.
- Poly- ⁇ -caprolactone purchased from WAKO CHEMICAL: weight average molecular weight from 70,000 to 100,000
- chloroform purchased from WAKO CHEMICAL
- the hydrophobic polymer aqueous solution was spin-coated on a silicon wafer (for measuring a contact angle) of 10 x 20 mm 2 or a cover glass (for cell culture) having a diameter of 15 mm to form a poly- ⁇ - caprolactone-containing thin film having a film thickness of approximately 100 nm.
- the spin coating conditions were that a maximum rotational number was 3,000 and a time was 30 seconds. After the spin coating, the product was allowed to stand still and dried at room temperature.
- an ultrathin film of less than 50 nm has to be formed on a metallic thin film sensor chip (measurable lower limit is 60 nm).
- poly- ⁇ -caprolactone was dissolved in chloroform to adjust a concentration to 0.7% w/w, and the solution was spin-coated on the surface to form a poly- ⁇ - caprolactone-containing thin film having a film thickness of approximately 51 nm.
- the spin coating conditions were that a maximum rotational number was 3,000 rpm and a time was 30 seconds. After the spin coating, the product was allowed to stand still and dried at room temperature.
- PO polypropylene oxide
- EO polyethylene oxide
- Comparative Example 1 a polystyrene surface was formed in the same manner as in Example 1 except that a polymer chain having a hydrophilic skeleton was not grafted.
- Comparative Example 2 a poly- ⁇ -caprolactone surface was formed in the same manner as in Example 2 except that a polymer chain having a hydrophilic skeleton was not grafted.
- a static contact angle to water of the surface prepared in each of Examples 1 to 3 and Comparative Examples 1 and 2 was measured using a contact angle measuring apparatus (DropMaster 500, manufactured by Kaimen Kagaku). The results are shown in Table 1.
- SPR Surface Plasmon Resonance
- a measurement principle of the apparatus is described below.
- a laser beam is applied to a surface of a metallic thin film sensor chip having a thickness of 50 nm via a prism, a peculiar light absorption (decay of reflected light) is observed at a prescribed angle of a total reflection angle region. This is a phenomenon called surface plasmon resonance.
- a certain molecule is immobilized on a surface of a metallic thin film sensor chip, a refractive index of an interface between the metallic thin film sensor chip surface and a liquid flowing thereon is changed to change an angle of a dark line (SPR angle) given to reflected light.
- SPR angle dark line
- the change in SPR angle induced by binding or dissociation of a molecule on the metallic thin film sensor chip surface is proportional to a change in mass of a binding molecule, and this change is recorded as a sensorgram.
- a sample is added to the surface of the metallic thin film sensor chip, and molecules interact and the signal of the sensorgram is increased. When the interaction reaches equilibrium, the signal remains in a prescribed value.
- the binding molecules are dissociated to decrease the signal of the sensorgram. Consequently, regarding the interaction of molecules such as recognition, binding or dissociation, a complete profile can be obtained in real time. From this profile, specificity of interaction, affinity, kitics, and a concentration and an adsorption amount of a desired molecule can be found.
- a measurement sample was set on an SPR measuring apparatus to measure an adsorption amount of fibronectin at room temperature (approximately 25°C) with a flow rate of 30 ⁇ l of an Fn solution/min.
- the results are shown in Table 1 and Fig. 1.
- the surface prepared in each of Examples 1 to 3 and Comparative Examples 1 and 2 was sterilized with an ethylene oxide gas (40°C, 20 minutes). The sterilized surface was then inserted into a bottom of a 24-well cell culture dish (purchased from IWAKI). L6 cells (Cell Line derived from a mouse skeletal muscle: purchased from ATCC) in cell number of 40 cells/mm 2 were seeded, and cultured in DMEM (1% penicillin/streptomycin and 10% fetal bovine serum) at 37°C for 4 days in the presence of 5% CO 2 . As a reference, an untreated surface was also subjected to the test under the same conditions. The cell number was measured on day 1 and day 4 of the culture. The measurement was conducted using WST Assay Kit (manufactured by DOJINDO). The results are shown in Table 1 and Fig. 2.
- Example 1 the cell culture was conducted using the surface obtained by grafting the polymer chain having a hydrophilic skeleton on the hydrophobic polymer skeleton (Examples 1 to 3), with the result that the viable cell number on day 4 of the cell culture was outstandingly increased relative to the viable cell number on day 1 in comparison with the untreated surface (Comparative Examples 1 and 2).
- Comparative Example 1 the viable cell number on day 4 of the cell culture was decreased relative to the viable cell number on day 1. This indicates that cells cannot exist on the polystyrene surface for a long period of time.
- the cell culture substrate of the invention makes it possible to improve efficiency of the cell culture without the necessity of immobilization and adsorption of the cell adhesion substance on the substrate surface.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Clinical Laboratory Science (AREA)
- Sustainable Development (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08778220A EP2173857A1 (en) | 2007-07-11 | 2008-07-10 | Cell culture substrate |
US12/600,037 US20100273260A1 (en) | 2007-07-11 | 2008-07-10 | Cell culture substrate and process for producing the same and method for culturing cells |
CA002686588A CA2686588A1 (en) | 2007-07-11 | 2008-07-10 | Cell culture substrate and process for producing the same and method for culturing cells |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007181913A JP5162784B2 (en) | 2007-07-11 | 2007-07-11 | Cell culture substrate, method for producing the same, and cell culture method |
JP2007-181913 | 2007-07-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009008547A1 true WO2009008547A1 (en) | 2009-01-15 |
Family
ID=39735347
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/062869 WO2009008547A1 (en) | 2007-07-11 | 2008-07-10 | Cell culture substrate |
Country Status (6)
Country | Link |
---|---|
US (1) | US20100273260A1 (en) |
EP (1) | EP2173857A1 (en) |
JP (1) | JP5162784B2 (en) |
KR (1) | KR20100049532A (en) |
CA (1) | CA2686588A1 (en) |
WO (1) | WO2009008547A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11193107B2 (en) | 2015-02-25 | 2021-12-07 | Ebara Jitsugyo Co., Ltd. | Substrate for supporting cells and method for producing same |
EP4276462A1 (en) | 2022-05-13 | 2023-11-15 | Robert Bosch Gesellschaft für medizinische Forschung mbH | Polymer device for in-vitro drug evaluation |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL2895595T3 (en) * | 2012-09-14 | 2019-07-31 | Charm Sciences, Inc. | Culture medium method and device |
US11427849B2 (en) | 2012-10-25 | 2022-08-30 | Charm Sciences, Inc. | Culture medium method and device |
US10407654B1 (en) | 2014-03-21 | 2019-09-10 | Charm Sciences, Inc. | Growth plate devices, kits and assemblies |
JP2015195762A (en) * | 2014-04-01 | 2015-11-09 | 大日本印刷株式会社 | cell culture vessel |
JP6866873B2 (en) * | 2018-05-03 | 2021-04-28 | 東洋製罐グループホールディングス株式会社 | Method for manufacturing culture container base material, culture container, and culture container base material |
JP6801728B2 (en) * | 2019-03-08 | 2020-12-16 | 住友ベークライト株式会社 | Analytical device |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990000595A1 (en) * | 1988-07-05 | 1990-01-25 | Banes Albert J | Floating cell culture device and method |
WO2000078927A2 (en) * | 1999-06-17 | 2000-12-28 | University Of Wales College Of Medicine | Spheroid preparation |
EP1095967A1 (en) * | 1999-10-29 | 2001-05-02 | Computer Cell Culture Center S.A. | Novel cell culture supports carrying special properties and their production |
WO2002035992A2 (en) * | 2000-10-30 | 2002-05-10 | Children's Medical Center Corporation | Tissue-engineered vascular structures |
US20020064875A1 (en) * | 2000-10-06 | 2002-05-30 | Industrial Technology Research Institute | Carrier for cell attachment or fixation and its process for preparation |
WO2003042376A1 (en) * | 2001-11-15 | 2003-05-22 | Photothera, Inc. | Methods for preparing artificial cartilage |
US20060073588A1 (en) * | 2004-10-01 | 2006-04-06 | Isto Technologies, Inc. | Method for chondrocyte expansion with phenotype retention |
WO2007108003A2 (en) * | 2006-03-23 | 2007-09-27 | Pluristem Ltd. | Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0923876A (en) * | 1995-07-11 | 1997-01-28 | Kao Corp | Production of supporting material for cell culture |
JP4731044B2 (en) * | 2001-05-22 | 2011-07-20 | 独立行政法人理化学研究所 | Stretched film and cell culture substrate using the same |
JP4950426B2 (en) * | 2005-02-17 | 2012-06-13 | 株式会社日立製作所 | Nerve cell culture method, neuron culture substrate and method for producing neuron system |
JP2006304734A (en) * | 2005-05-02 | 2006-11-09 | Teijin Ltd | Cell culture apparatus |
JP2007049918A (en) * | 2005-08-17 | 2007-03-01 | Onecell Inc | Cell culture support, cell culture method, recovery of cell, and cell |
JP2007166910A (en) * | 2005-12-19 | 2007-07-05 | Fujifilm Corp | Multiple-layered cell-cultured material including respiratory tract epithelial cell |
WO2007074747A1 (en) * | 2005-12-26 | 2007-07-05 | Kuraray Co., Ltd. | Material for cell culture |
EP1873205A1 (en) * | 2006-06-12 | 2008-01-02 | Corning Incorporated | Thermo-responsive blends and uses thereof |
-
2007
- 2007-07-11 JP JP2007181913A patent/JP5162784B2/en not_active Expired - Fee Related
-
2008
- 2008-07-10 WO PCT/JP2008/062869 patent/WO2009008547A1/en active Application Filing
- 2008-07-10 CA CA002686588A patent/CA2686588A1/en not_active Abandoned
- 2008-07-10 KR KR1020107000066A patent/KR20100049532A/en not_active Application Discontinuation
- 2008-07-10 EP EP08778220A patent/EP2173857A1/en not_active Withdrawn
- 2008-07-10 US US12/600,037 patent/US20100273260A1/en not_active Abandoned
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990000595A1 (en) * | 1988-07-05 | 1990-01-25 | Banes Albert J | Floating cell culture device and method |
WO2000078927A2 (en) * | 1999-06-17 | 2000-12-28 | University Of Wales College Of Medicine | Spheroid preparation |
EP1095967A1 (en) * | 1999-10-29 | 2001-05-02 | Computer Cell Culture Center S.A. | Novel cell culture supports carrying special properties and their production |
US20020064875A1 (en) * | 2000-10-06 | 2002-05-30 | Industrial Technology Research Institute | Carrier for cell attachment or fixation and its process for preparation |
WO2002035992A2 (en) * | 2000-10-30 | 2002-05-10 | Children's Medical Center Corporation | Tissue-engineered vascular structures |
WO2003042376A1 (en) * | 2001-11-15 | 2003-05-22 | Photothera, Inc. | Methods for preparing artificial cartilage |
US20060073588A1 (en) * | 2004-10-01 | 2006-04-06 | Isto Technologies, Inc. | Method for chondrocyte expansion with phenotype retention |
WO2007108003A2 (en) * | 2006-03-23 | 2007-09-27 | Pluristem Ltd. | Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11193107B2 (en) | 2015-02-25 | 2021-12-07 | Ebara Jitsugyo Co., Ltd. | Substrate for supporting cells and method for producing same |
EP4276462A1 (en) | 2022-05-13 | 2023-11-15 | Robert Bosch Gesellschaft für medizinische Forschung mbH | Polymer device for in-vitro drug evaluation |
Also Published As
Publication number | Publication date |
---|---|
CA2686588A1 (en) | 2009-01-15 |
KR20100049532A (en) | 2010-05-12 |
EP2173857A1 (en) | 2010-04-14 |
US20100273260A1 (en) | 2010-10-28 |
JP2009017809A (en) | 2009-01-29 |
JP5162784B2 (en) | 2013-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Xu et al. | Surface functionalization of polycaprolactone films via surface-initiated atom transfer radical polymerization for covalently coupling cell-adhesive biomolecules | |
US11786639B2 (en) | Promoting endothelial cell affinity and antithrombogenicity of polytetrafluoroethylene (PTFE) by mussel-inspired modification and RGD/heparin grafting | |
US20100273260A1 (en) | Cell culture substrate and process for producing the same and method for culturing cells | |
Cook et al. | Characterization and development of RGD‐peptide‐modified poly (lactic acid‐co‐lysine) as an interactive, resorbable biomaterial | |
Tamada et al. | Fibroblast growth on polymer surfaces and biosynthesis of collagen | |
Conzatti et al. | PNIPAM grafted surfaces through ATRP and RAFT polymerization: Chemistry and bioadhesion | |
Cheng et al. | Surface modification of ultra thin poly (ε-caprolactone) films using acrylic acid and collagen | |
Nash et al. | Cell and cell sheet recovery from pNIPAm coatings; motivation and history to present day approaches | |
Chen et al. | Control of cell attachment on pH-responsive chitosan surface by precise adjustment of medium pH | |
Solouk et al. | Biomimetic modified clinical-grade POSS-PCU nanocomposite polymer for bypass graft applications: A preliminary assessment of endothelial cell adhesion and haemocompatibility | |
Kubinová et al. | Cholesterol-modified superporous poly (2-hydroxyethyl methacrylate) scaffolds for tissue engineering | |
Hsiue et al. | Surface characterization and biological properties study of silicone rubber membrane grafted with phospholipid as biomaterial via plasma induced graft copolymerization | |
Tsai et al. | Polyelectrolyte multilayer films functionalized with peptides for promoting osteoblast functions | |
Kim et al. | Preparation of insulin-immobilized polyurethanes and their interaction with human fibroblasts | |
Hatakeyama et al. | Influence of insulin immobilization to thermoresponsive culture surfaces on cell proliferation and thermally induced cell detachment | |
Nakayama et al. | Water stable nanocoatings of poly (N-isopropylacrylamide)-based block copolymers on culture insert membranes for temperature-controlled cell adhesion | |
Utrata-Wesołek et al. | Thermoresponsive polymer surfaces and their application in tissue engineering | |
Park et al. | Enhancement of the adhesion of fibroblasts by peptide containing an Arg-Gly-Asp sequence with poly (ethylene glycol) into a thermo-reversible hydrogel as a synthetic extracellular matrix | |
Liu et al. | Cell attachment and detachment on micropattern-immobilized poly (N-isopropylacrylamide) with gelatin | |
CA2226131C (en) | Preparation of polymeric materials having cell poliferation-promoting properties | |
JPH03266980A (en) | Base material for cell culture and production of cell aggregate using same | |
Li et al. | Endothelial cell and platelet behavior on titanium modified with a mutilayer of polyelectrolytes | |
CA3170695A1 (en) | Multilayered membrane for spheroid culture | |
Guerron et al. | Selectively triggered cell detachment from poly (N-isopropylacrylamide) microgel functionalized substrates | |
Sariri | Protein interaction with novel hydrogel biomaterials |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08778220 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2686588 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12600037 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 20107000066 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 135/CHENP/2010 Country of ref document: IN Ref document number: 2008778220 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |